1 in 9 Canadian adults have had long term symptoms from COVID infection, StatCan saysAlmost 80% of those people with long-term symptoms have them for six months or more, the report said. Preventive use of amikacin can reduce cases of ventilator-acquired pneumoniaResearchers are now evaluating the possibility of starting preventive antibiotics after four or five days of ventilation. POP QUIZ: Inhalers and climate change Based on a recent Canadian Thoracic Society position statement, which of these statements is false? A technical pill to swallow: Patient vitals can be measured and recorded by ingesting this device A first step for a potential diagnostic tool for apnea and OIRD. Approaches to reduce inhaler-related greenhouse gas emissions Canadian Thoracic Society has issued a position statement on climate change and choice of inhalers in patients with respiratory diseases. Cold air keeps croup at bay, and now a study proves it Canadian docs often suggest parents take kids out into the cold. Face mask use reduces SARS-CoV-2 transmission in community settings Use of face masks in the community will be an important component of an effective response to any future respiratory threats. AMMI Canada issues 2023 update on influenza—management and emerging issues Discusses the potential role of multiplex respiratory testing for SARS-CoV-2, influenza virus and RSV, and emerging issues related to highly pathogenic avian influenza virus. Vaccine paves the way for new treatments for allergies A Franco-Quebec company is currently testing a vaccine that could treat human cat allergy and other common allergies in the future. Updated COVID-19 vaccine recommendations for unvaccinated individuals NACI issues updated guidance on the use of COVID-19 vaccines in individuals who have never been vaccinated against COVID-19. First Previous 5 6 7 8 9 Next Last